Cargando…
Topiramate for hypoxic ischemic encephalopathy: A systematic review protocol
BACKGROUND: Hypoxic ischemic encephalopathy (HIE) is brain injury caused by different reasons and the most common diagnosed is neonatal HIE. Most of the existing treatments have their own shortcomings or there are still some unexplained mechanisms in it. Topiramate (TPM) is a new drug for the treatm...
Autores principales: | Chen, Guoming, Chen, Yijun, Xie, Yaying, Huang, Ruilan, Chen, Tengyu, Shi, Peiyu, Zhang, Zhaoping, Hou, Yingyue, Xing, Wanli, Wei, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220522/ https://www.ncbi.nlm.nih.gov/pubmed/32332593 http://dx.doi.org/10.1097/MD.0000000000018704 |
Ejemplares similares
-
Effectiveness of dose-escalated topiramate monotherapy and add-on therapy in neurosurgery-related epilepsy: A prospective study
por: Liu, Yu-Tse, et al.
Publicado: (2020) -
Efficacy and Safety of Topiramate for Essential Tremor: A Meta-Analysis of Randomized Controlled Trials
por: Chang, Kuo-Hsuan, et al.
Publicado: (2015) -
Should topiramate be initial therapy in the management of idiopathic intracranial hypertension?: A literature review
por: Goyal, Abhishek, et al.
Publicado: (2023) -
Guizhi Gancao Longgu Muli decoction for insomnia: A protocol for a systematic review
por: Chen, Fangying, et al.
Publicado: (2020) -
Safety and efficacy of topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia (NeoNATI)
por: Filippi, Luca, et al.
Publicado: (2012)